Switching to exemestane after 2-3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen

被引：0
|
作者：
Davies, C [1 ]
机构：
[1] Univ Oxford, Studies Unit, Clin Trial Serv & Epidemiol, Oxford, England
来源：
CANCER TREATMENT REVIEWS | 2004年 / 30卷 / 06期
关键词：
D O I：
10.1016/j.ctrv.2004.06.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：583 / 588
页数：6
相关论文
共 50 条
  • [31] Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: Overall Survival Versus Disease-Free Survival As a Primary End Point in Clinical Practice
    Sanchez-Munoz, Alfonso
    Ribelles, Nuria
    Marquez, Antonia
    Perez-Ruiz, Elisabeth
    Alba, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : E255 - E256
  • [32] Ki-67 Expression after Tamoxifen Given Preoperatively Predicts Disease Free Survival and Overall Survival in Women with Operable ER-Positive Breast Cancer
    Decensi, A.
    Guerrieri-Gonzaga, A.
    Gandini, S.
    Serrano, D.
    Cazzaniga, M.
    Mora, S.
    Johansson, H.
    Lien, E. A.
    Luini, A.
    Pelosi, G.
    Bonanni, B.
    CANCER RESEARCH, 2009, 69 (24) : 517S - 518S
  • [33] Timing of Adjuvant Surgical Oophorectomy in the Menstrual Cycle and Disease-Free and Overall Survival in Premenopausal Women With Operable Breast Cancer
    Love, Richard R.
    Laudico, Adriano V.
    Nguyen Van Dinh
    Allred, D. Craig
    Uy, Gemma B.
    Le Hong Quang
    Salvador, Jonathan Disraeli S.
    Siguan, Stephen Sixto S.
    Mirasol-Lumague, Maria Rica
    Nguyen Dinh Tung
    Benjaafar, Noureddine
    Navarro, Narciso S., Jr.
    Tran Tu Quy
    De la Pena, Arturo S.
    Dofitas, Rodney B.
    Bisquera, Orlino C., Jr.
    Nguyen Dieu Linh
    Ta Van To
    Young, Gregory S.
    Hade, Erinn M.
    Jarjoura, David
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (06):
  • [34] The impact of age and adjuvant chemotherapy modifications on disease-free and overall survival among African American women with breast cancer
    Nugent, B. D.
    Ren, D.
    Bender, C.
    Rosenzweig, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [35] Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: Overall Survival Versus Disease-Free Survival As a Primary End Point in Clinical Practice Reply
    Montemurro, Filippo
    Del Mastro, Lucia
    Aglietta, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : E257 - E258
  • [36] A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer (vol 350, pg 1081, 2004)
    Coombes, R. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (16): : 1746 - 1746
  • [37] A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer (vol 350, pg 1081, 2004)
    Coombes, RC
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23): : 2461 - 2461
  • [38] Increased Progression Free and Overall Survival in Breast Cancer Patients with Menopausal Symptoms or Arthralgia/Myalgia during Adjuvant Treatment with Exemestane or Tamoxifen Results of the German TEAM Trial
    Hadji, P.
    Kieback, D. G.
    Hasenburg, A.
    Tams, J.
    Ziller, M.
    CANCER RESEARCH, 2011, 71
  • [39] Increased progression-free and overall survival in patients with breast cancer with menopausal symptoms or arthralgia/myalgia during adjuvant treatment with exemestane or tamoxifen: Results of the German TEAM trial
    Kieback, D. G.
    Hadji, P.
    Menschik, T.
    Hasenburg, A.
    Tams, J.
    Ziller, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
    Nordenskjold, Anna
    Fohlin, Helena
    Rosell, Johan
    Bengtsson, Nils-Olof
    Fornander, Tommy
    Hatschek, Thomas
    Lindman, Henrik
    Malmstrom, Per
    Ryden, Lisa
    Wallgren, Arne
    Stal, Olle
    Nordenskjold, Bo
    BREAST, 2023, 71 : 63 - 68
12345